Ketchersid Kimberlee
Kimberlee Ketchersid practices in hospital medicine at VCU Health System in Richmond, Va., and is the manager of the APP Transition to Practice Program. The author has disclosed no potential conflicts of interest, financial or otherwise.
JAAPA. 2023 Mar 1;36(3):16-19. doi: 10.1097/01.JAA.0000918776.59717.eb.
Organizing pneumonia is a clinical and pathological syndrome that describes a lung injury caused by an inflammatory reaction in the alveolar connective tissue. Classified as an interstitial lung disease, it can be secondary to infection, drug toxicity, connective tissue disorders, inhalation injuries (cocaine), organ transplant, or radiotherapy, and also can be idiopathic. Although organizing pneumonia is not a new phenomenon, it has been noted to be a complication of COVID-19, and should be considered in patients who have had COVID-19 and have atypical chest imaging, because treatment includes corticosteroids instead of antimicrobials.
机化性肺炎是一种临床和病理综合征，描述了肺泡结缔组织炎症反应引起的肺损伤。它被归类为间质性肺疾病，可继发于感染、药物毒性、结缔组织疾病、吸入性损伤（如可卡因）、器官移植或放疗，也可为特发性。尽管机化性肺炎并非新现象，但已被注意到是新型冠状病毒肺炎（COVID-19）的一种并发症，对于曾患COVID-19且胸部影像学表现不典型的患者应予以考虑，因为治疗包括使用糖皮质激素而非抗菌药物。
